Please wait
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
______________________
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
______________________
|  |  |  |  |  |  |  |  |  |  |  |  | 
| Filed by the Registrant | x | Filed by a Party other than the Registrant | o | 
|  |  |  |  |  |  | 
| Check the appropriate box: | 
|  | 
| o | Preliminary Proxy Statement | 
|  | 
| o | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) | 
|  | 
| o | Definitive Proxy Statement | 
|  | 
| x | Definitive Additional Materials | 
|  | 
| o | Soliciting Material Pursuant to §240.14a-12 | 
10x Genomics, Inc.
(Name of Registrant as Specified In Its Charter)
|  |  |  |  |  |  |  |  |  | 
| Payment of Filing Fee (Check the appropriate box): | 
|  | 
| x | No fee required. | 
|  |  |  | 
|  |  |  | 
| o | Fee paid previously with preliminary materials. | 
|  |  |  | 
| o | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i) and 0-11 | 
|  |  |  |